Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A drug for treating cerebral thrombosis

A technology of cerebral thrombosis and drugs, applied in the field of drugs for the treatment of cerebral thrombosis, can solve the problems of large side effects and achieve the effect of treating cerebral thrombosis with less toxic side effects

Inactive Publication Date: 2016-01-20
SHANDONG PROVINCIAL HOSPITAL
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The treatment methods for cerebral thrombosis include: taking anticoagulation, thrombolysis, vasodilator drugs and surgical treatment, etc., with relatively large side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Ratio: 20g ginseng, 25g rehmannia glutinosa, 15g sealwort, 15g longan meat, 20g jujube seed, 20g poria cocos, 15g Atractylodes macrocephala, 15g citron, 20g dried tangerine peel, 10g Polygonatum odoratum, 10g melon seeds, 20g lotus leaf, 20g Eucommia, Uncaria 20g, Gastrodia elata 15g, seabuckthorn 15g, honeysuckle vine 20g, salvia miltiorrhiza 15g, knotweed 20g, hedyotis diffusa 15g, dandelion 15g, spatholobus 20g, black sesame 10g, cassia seed 15g, gallinacea 15g and licorice 5g.

[0049] Preparation and administration method: decoct in water, take twice in the morning and evening. 10 days is a course of treatment, generally take 2-5 courses of treatment.

Embodiment 2

[0051] Ratio: Ginseng 25g, Rehmannia glutinosa 27g, Polygonatum 18g, Longan meat 18g, Suanzaoren 25g, Poria cocos 22g, Atractylodes macrocephala 18g, Citron 18g, Tangerine peel 22g, Polygonatum 12g, Gualouzi 12g, Lotus leaf 22g, Eucommia 122g, Uncaria 22g, Gastrodia elata 18g, seabuckthorn 18g, honeysuckle vine 22g, salvia miltiorrhiza 18g, knotweed 22g, hedyotis diffusa 18g, dandelion 18g, spatholobus 22g, black sesame 12g, cassia seed 18g, gallinacea 18g and licorice 8g.

[0052] Preparation and administration method: with embodiment 1.

Embodiment 3

[0054] Ratio: 20g ginseng, 22g rehmannia glutinosa, 12g sealwort, 12g longan meat, 15g jujube seed, 18g poria cocos, 12g atractylodes macrocephala, 12g citron, 18g tangerine peel, 8g Polygonatum 8g, 8g melon seeds, 18g lotus leaf, 18g Eucommia, Uncaria 18g, Gastrodia elata 12g, seabuckthorn 12g, honeysuckle vine 18g, salvia miltiorrhiza 12g, knotweed 18g, hedyotis diffusa 12g, dandelion 12g, spatholobus 18g, black sesame 8g, cassia seed 12g, gallinaceae 12g and licorice 3g.

[0055] Preparation and administration method: with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating cerebral thrombosis. The medicine is prepared from the following bulk drugs: ginseng, prepared rehmannia, polygonatum kingianum, longan pulp, semen ziziphi spinosae, poria, bighead atractylodes rhizome, citron fruit, dried tangerine peel, polygonatum odoratum, semen trichosanthis, lotus leaf, eucommia, uncaria, gastrodia elata, sea-buckthorn, honeysuckle stem, salviae miltiorrhizae, polygonum cuspidatum, oldenlandia diffusa, dandelion, spatholobus suberctu, black sesame, cassia seed, endothelium corneum gigeriae galli and liquorice. The medicine has the effects of dissolving thrombus, resisting coagulation, strengthening vessel tensile force, reducing blood pressure and fat and strengthening brain, can effectively treat cerebral thrombosis. The total effective rate of the medicine for treating cerebral thrombosis is 100 percent.

Description

technical field [0001] The invention relates to a medicine for treating cerebral thrombosis and belongs to the technical field of traditional Chinese medicine. Background technique [0002] Cerebral thrombosis is the most common type of cerebral infarction, more common in middle-aged and elderly people. Cerebral artery trunk or cortical branch atherosclerosis leads to thickening of blood vessels, stenosis and occlusion of the lumen, and thrombosis, resulting in reduced or interrupted blood flow in the brain, cerebral ischemia and hypoxia lead to softening and necrosis, and focal nervous system Symptoms and signs. Therefore, it is also called "atherosclerotic cerebral thrombosis" or "thrombotic cerebral infarction" clinically. [0003] Before the onset of the disease, the patient had symptoms such as limb numbness, ineffective movement, slurred speech, dizziness, and blurred vision. The onset often occurs during sleep or in the morning. The affected limb is weak or unable ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8988A61P9/10A61P7/02A61K35/57
Inventor 王翔王晓娜
Owner SHANDONG PROVINCIAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com